Ricoh Co. Ltd. ADS (RICOY) Financials Nov 7, 2014, 12:00

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Ricoh Co. Ltd. ADS (RICOY) Financials Nov 7, 2014, 12:00 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Ricoh Co. Ltd. ADS


Fiscal year is April-March. All values JPY millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 2.02T 1.94T 1.9T 1.89T 2.2T
Cost of Goods Sold (COGS) incl. D&A 1.19T 1.15T 1.15T 1.17T 1.34T
COGS excluding D&A 1.1T 1.06T 1.06T 1.08T 1.23T
Depreciation & Amortization Expense 98.94B 93.4B 91.14B 95.92B 106.23B
Depreciation 70.33B 67.24B 64.98B - -
Amortization of Intangibles 28.61B 26.16B 26.15B - -
Gross Income 822.34B 790.41B 756.56B 714.21B 857.96B
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 756.35B 729.5B 713.03B 640.65B 737.62B
Research & Development 109.83B 110.82B 110.89B 89.43B 116.22B
Other SG&A 646.52B 618.68B 602.14B 551.23B 621.4B
Other Operating Expense 0 0 0 0 0
Unusual Expense 169M 5B 71.43B 1.01B 17M
EBIT after Unusual Expense (169M) (5B) (71.43B) (1.01B) (17M)
Non Operating Income/Expense (3.63B) (5.12B) (238M) 1.66B 4.06B
Non-Operating Interest Income 3.47B 2.99B 3.13B 1.16B 1.1B
Equity in Affiliates (Pretax) 0 - - - -
Interest Expense 8.14B 8.37B 6.93B 7.32B 7.39B
Gross Interest Expense 8.14B 8.37B 6.93B 7.32B 7.39B
Interest Capitalized - 0 0 0 0
Pretax Income 57.52B 45.4B (31.94B) 68.05B 118.1B
Income Tax 27.68B 22.62B 8.22B 24.26B 39.61B
Income Tax - Current Domestic 26.9B (2.82B) 13.3B 24.44B 32.86B
Income Tax - Current Foreign 598M 24.49B 19.01B - -
Income Tax - Deferred Domestic (3.51B) 639M (15.44B) (171M) 6.76B
Income Tax - Deferred Foreign 3.69B 317M (8.64B) - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 6M (22M) 39M 31M (33M)
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 29.85B 22.76B (40.12B) 43.82B 78.45B
Minority Interest Expense 1.98B 3.11B 4.44B 4.9B 5.63B
Net Income 27.87B 19.65B (44.56B) 38.92B 72.82B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 27.87B 19.65B (44.56B) 38.92B 72.82B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 27.87B 19.65B (44.56B) 38.92B 72.82B
EPS (Basic) 38.41 27.08 (61.42) 53.67 100.44
Basic Shares Outstanding 725.61M 725.56M 725.48M 725.06M 724.98M
EPS (Diluted) 37.36 26.53 (61.42) 53.67 100.44
Diluted Shares Outstanding 745.35M 739.29M 725.48M 725.06M 724.98M
EBITDA 164.94B 154.3B 134.66B 169.47B 226.58B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Agilyx ASA Secures EUR 14 Million for Strategic Growth Plan

Updated Category News Views 136

Agilyx ASA Enhances Liquidity with EUR 14 Million Bond Placement In a significant move to boost its liquidity and support its long-term strategic objectives, Agilyx ASA has successfully executed a bond tap issue, raising EUR 14 million through additional convertible bonds. This placement follows previous notices concerning the issuance of EUR 24 million in convertible...

Continue Reading
Understanding Legal Actions Against Flywire Corporation's Management

Updated Category News Views 178

Class Action Notice for Flywire Corporation Investors In recent developments, Robbins LLP has issued a reminder to investors regarding a class action lawsuit concerning Flywire Corporation (NASDAQ: FLYW). This action primarily affects stockholders who purchased or acquired shares of Flywire from a specified period. Flywire is a prominent payments-enablement and software...

Continue Reading
PharmaCorp to Raise C$15 Million in New Unit Offering

Updated Category News Views 102

PharmaCorp's Recent Public Offering Announcement PharmaCorp Rx Inc. (TSXV: PCRX) has revealed plans for a public offering aimed at raising C$15 million. This initiative looks to support the company's strategy of acquiring pharmacies and enhancing operations within the sector. This offering represents a significant opportunity for investors to participate in PharmaCorp's...

Continue Reading
Blue Moon Metals Finalizes Acquisitions and Announces New Leadership

Updated Category News Views 354

Recent Acquisitions by Blue Moon Metals Blue Moon Metals Inc. (TSXV: MOON) has successfully concluded its recent acquisitions involving Nussir ASA and Nye Sulitjelma Gruver AS. These strategic moves are expected to expand Blue Moon's operational footprint significantly, enhancing its portfolio in the mining sector. The acquisition has resulted in Blue Moon obtaining a...

Continue Reading
Celebrating Brad S. Snavely: Pinnacle Member in Agronomics

Updated Category News Views 115

Brad S. Snavely's Recognition as Pinnacle Professional Member Brad S. Snavely has been prominently featured as a Pinnacle Professional Member in The Inner Circle for his significant contributions to agronomics and innovations in sports turf. His work has led to changes that impact not only the industry but also communities across the nation. Impact on Agronomics and...

Continue Reading